Journal
CLINICAL RHEUMATOLOGY
Volume 29, Issue 10, Pages 1201-1204Publisher
SPRINGER LONDON LTD
DOI: 10.1007/s10067-010-1466-7
Keywords
Adalimumab; Anti-TNF; Cerebral; Rheumatoid arthritis; Tuberculoma
Categories
Ask authors/readers for more resources
We report a case of a cerebral tuberculoma in a 60-year-old woman with rheumatoid arthritis while receiving the anti-tumor necrosis factor alpha monoclonal antibody, adalimumab (Humira), for active disease. MR brain imaging for dyspraxia revealed a left parietal ring-enhancing lesion, which on resection was shown to be a necrotizing granuloma. There were no associated pulmonary lesions, and the patient was systemically well. Sputum and urine cultures were negative for tuberculosis. The patient was treated with anti-tuberculous medications and made an excellent recovery. We consider this to be the first documented case of tuberculosis involving the central nervous system occurring in the setting of adalimumab treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available